News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Sanofi-Aventis (France), GlaxoSmithKline Eyes Troubled Genzyme Corporation; Genzyme Rebuffs Sanofi Bid
July 23, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Genzyme Corp (GENZ.O) has turned down a bid to be acquired by French drugmaker Sanofi-Aventis (SASY.PA), Bloomberg reported on Monday, citing two people with knowledge of the matter.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Mergers & acquisitions
GlaxoSmithKline
Sanofi
MORE ON THIS TOPIC
Funding
Backed by Sanofi, Pfizer, Earendil Bags $787M for AI-Driven Biologics Design
March 23, 2026
·
2 min read
·
Tristan Manalac
Parkinson’s disease
Oryon Splashes Onto Parkinson’s Scene With $42M for Cell Therapy
March 23, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
Gossamer, BiomX Reveal Hefty Staff Cuts
March 20, 2026
·
39 min read
·
BioSpace Editorial Staff
Policy
Biopharma Could Provide a Haven for Investment as Middle East Conflict Roils Global Markets
March 20, 2026
·
2 min read
·
Annalee Armstrong